Logo image of SRP.PA

SHOWROOMPRIVE (SRP.PA) Stock Fundamental Analysis

EPA:SRP - Euronext Paris - Matif - FR0013006558 - Common Stock - Currency: EUR

0.85  +0 (+0.24%)

Fundamental Rating

3

Overall SRP gets a fundamental rating of 3 out of 10. We evaluated SRP against 54 industry peers in the Specialty Retail industry. SRP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SRP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SRP had negative earnings in the past year.
SRP had a positive operating cash flow in the past year.
Of the past 5 years SRP 4 years were profitable.
SRP had a positive operating cash flow in 4 of the past 5 years.
SRP.PA Yearly Net Income VS EBIT VS OCF VS FCFSRP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

SRP has a Return On Assets (0.12%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 0.27%, SRP is in line with its industry, outperforming 52.83% of the companies in the same industry.
With a Return On Invested Capital value of 0.26%, SRP perfoms like the industry average, outperforming 47.17% of the companies in the same industry.
SRP had an Average Return On Invested Capital over the past 3 years of 2.19%. This is significantly below the industry average of 9.99%.
Industry RankSector Rank
ROA 0.12%
ROE 0.27%
ROIC 0.26%
ROA(3y)2.14%
ROA(5y)-1.76%
ROE(3y)4.57%
ROE(5y)-4.95%
ROIC(3y)2.19%
ROIC(5y)N/A
SRP.PA Yearly ROA, ROE, ROICSRP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

1.3 Margins

With a Profit Margin value of 0.07%, SRP perfoms like the industry average, outperforming 52.83% of the companies in the same industry.
In the last couple of years the Profit Margin of SRP has declined.
SRP's Operating Margin of 0.17% is in line compared to the rest of the industry. SRP outperforms 47.17% of its industry peers.
In the last couple of years the Operating Margin of SRP has declined.
Looking at the Gross Margin, with a value of 38.23%, SRP is in line with its industry, outperforming 58.49% of the companies in the same industry.
SRP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.17%
PM (TTM) 0.07%
GM 38.23%
OM growth 3Y-62.98%
OM growth 5YN/A
PM growth 3Y-66.85%
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y1.06%
SRP.PA Yearly Profit, Operating, Gross MarginsSRP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRP is destroying value.
SRP has less shares outstanding than it did 1 year ago.
SRP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRP has been reduced compared to a year ago.
SRP.PA Yearly Shares OutstandingSRP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SRP.PA Yearly Total Debt VS Total AssetsSRP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that SRP is in the distress zone and has some risk of bankruptcy.
SRP has a Altman-Z score (1.74) which is in line with its industry peers.
SRP has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
SRP's Debt to Equity ratio of 0.19 is amongst the best of the industry. SRP outperforms 84.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.04
WACC6.12%
SRP.PA Yearly LT Debt VS Equity VS FCFSRP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.97 indicates that SRP may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.97, SRP is doing worse than 67.92% of the companies in the same industry.
SRP has a Quick Ratio of 0.97. This is a bad value and indicates that SRP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.52, SRP is in line with its industry, outperforming 41.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.52
SRP.PA Yearly Current Assets VS Current LiabilitesSRP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

SRP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.56%, which is quite impressive.
The earnings per share for SRP have been decreasing by -70.58% on average. This is quite bad
SRP shows a small growth in Revenue. In the last year, the Revenue has grown by 3.01%.
Measured over the past years, SRP shows a small growth in Revenue. The Revenue has been growing by 0.15% on average per year.
EPS 1Y (TTM)55.56%
EPS 3Y-70.58%
EPS 5YN/A
EPS Q2Q%-648.54%
Revenue 1Y (TTM)3.01%
Revenue growth 3Y-0.98%
Revenue growth 5Y0.15%
Sales Q2Q%-4%

3.2 Future

SRP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.67% yearly.
SRP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.98% yearly.
EPS Next Y-1366.67%
EPS Next 2Y-82.57%
EPS Next 3Y38.67%
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y0.02%
Revenue Next 3Y0.98%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SRP.PA Yearly Revenue VS EstimatesSRP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
SRP.PA Yearly EPS VS EstimatesSRP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 -0.2

1

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for SRP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRP.PA Price Earnings VS Forward Price EarningsSRP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

69.81% of the companies in the same industry are more expensive than SRP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.13
SRP.PA Per share dataSRP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A more expensive valuation may be justified as SRP's earnings are expected to grow with 38.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-82.57%
EPS Next 3Y38.67%

0

5. Dividend

5.1 Amount

SRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHOWROOMPRIVE

EPA:SRP (3/7/2025, 7:00:00 PM)

0.85

+0 (+0.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-17 2024-10-17
Earnings (Next)03-13 2025-03-13/amc
Inst Owners0.36%
Inst Owner ChangeN/A
Ins Owners56.36%
Ins Owner ChangeN/A
Market Cap101.06M
Analysts45.71
Price Target0.92 (8.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF 30.51
P/B 0.55
P/tB N/A
EV/EBITDA 6.13
EPS(TTM)0
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.03
OCFY3.28%
SpS5.7
BVpS1.53
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.12%
ROE 0.27%
ROCE 0.54%
ROIC 0.26%
ROICexc 0.35%
ROICexgc N/A
OM 0.17%
PM (TTM) 0.07%
GM 38.23%
FCFM N/A
ROA(3y)2.14%
ROA(5y)-1.76%
ROE(3y)4.57%
ROE(5y)-4.95%
ROIC(3y)2.19%
ROIC(5y)N/A
ROICexc(3y)3.62%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.57%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-62.98%
OM growth 5YN/A
PM growth 3Y-66.85%
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y1.06%
F-Score8
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 2.26
Cap/Depr 91.08%
Cap/Sales 1.93%
Interest Coverage 250
Cash Conversion 21.34%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.52
Altman-Z 1.74
F-Score8
WACC6.12%
ROIC/WACC0.04
Cap/Depr(3y)66.41%
Cap/Depr(5y)71.5%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.69%
Profit Quality(3y)1118.96%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.56%
EPS 3Y-70.58%
EPS 5YN/A
EPS Q2Q%-648.54%
EPS Next Y-1366.67%
EPS Next 2Y-82.57%
EPS Next 3Y38.67%
EPS Next 5YN/A
Revenue 1Y (TTM)3.01%
Revenue growth 3Y-0.98%
Revenue growth 5Y0.15%
Sales Q2Q%-4%
Revenue Next Year-3.04%
Revenue Next 2Y0.02%
Revenue Next 3Y0.98%
Revenue Next 5YN/A
EBIT growth 1Y-66.41%
EBIT growth 3Y-63.34%
EBIT growth 5YN/A
EBIT Next Year138.1%
EBIT Next 3Y111.97%
EBIT Next 5YN/A
FCF growth 1Y8.92%
FCF growth 3Y-64.04%
FCF growth 5YN/A
OCF growth 1Y800.42%
OCF growth 3Y-36.23%
OCF growth 5Y9.25%